ArticlePediatric investigation2025
Application of machine learning in constructing a diagnostic model for neonatal biliary atresia.
Article in Pediatric investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial intelligence-guided nutritional therapy in the ICU.Current opinion in clinical nutrition and metabolic care · 2026Review
- Applications of artificial intelligence in pediatric general surgery: a systematic review.Translational pediatrics · 2026Review
- Application of machine learning in constructing a diagnostic model for neonatal biliary atresia.Pediatric investigation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Early diagnosis of biliary atresia (BA) is important for advancing the Kasai operation time and improving the BA prognosis. Objective: To develop machine learning (ML) models for neonatal BA diagnosis using clinical characteristics and serological data. Methods: Neonates presenting with pathological jaundice between January 1, 2013, and December 31, 2023 were enrolled. Five ML models-logistic regression (LR), random forest (RF), support vector machine classifier (SVC), multilayer perceptron (MLP), and extreme gradient boosting (XGBoost)-were trained using neonatal clinical and laboratory data. The stacking classifier (SC) algorithm was employed to select the best-performing models for constructing the ensemble learning model. Results: This study included 85 patients, 42 of whom were diagnosed with BA. Among the five ML models, XGBoost (area under the receiver operating characteristic curve [AUC] = 1.000; 95% confidence interval [CI]: 1.000-1.000) and the RF (AUC = 1.000; 95% CI: 1.000-1.000) demonstrated better diagnostic performance. All models showed acceptable consistency between the predicted and actual probabilities. The SC model, built on the LR, RF, and XGBoost models, also exhibited a strong generalization ability and diagnostic performance (AUC = 1.000; 95% CI: 1.000-1.000). Key diagnostic predictors included elevated gamma-glutamyl transpeptidase (GGT) (AUC = 0.837; 95% CI: 0.749-0.925), increased platelet (PLT) counts (AUC = 0.728; 95% CI: 0.618-0.838), and acholic stools (AUC = 0.765; 95% CI: 0.663-0.867). An XGBoost-based nomogram was also developed. Interpretation: ML models demonstrate high diagnostic accuracy for BA in neonates, with GGT, PLT counts, and acholic stools as pivotal predictors. This approach may enable earlier BA identification and intervention during the neonatal period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.